专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20050009797A1 Androstane derivative having substituent in 7- abd 17--positions 审中-公开
标题翻译：在7-abd 17位具有取代基的雄甾烷衍生物
公开(公告)号：US20050009797A1
公开(公告)日：2005-01-13
申请号：US10499044
申请日：2002-12-19
申请人： Mitsuaki Nakamura , Kazutaka Tachibana , Ikuhiro Imaoka , Hitoshi Yoshino , Setsu Kawata
发明人： Mitsuaki Nakamura , Kazutaka Tachibana , Ikuhiro Imaoka , Hitoshi Yoshino , Setsu Kawata
IPC分类号： A61P5/28 , A61P13/08 , A61P15/08 , A61P17/08 , A61P17/10 , A61P17/14 , A61P35/00 , C07J3/00 , A61K31/56 , C07J1/00
CPC分类号： C07J3/00
摘要： A compound of Formula (I): [wherein R1 represents a lower alkyl group, X represents an oxygen atom or a methylene group, m represents an integer of 1 to 10, and n represents an integer of 0 to 5] or a salt or ester thereof; a medicament and a pharmaceutical composition comprising one or more such compounds; a method for preventing or treating a disease closely related to androgen, which comprises administering an effective amount of one or more such compounds; a kit used for such prevention or treatment; and the use of one or more such compounds for the manufacture of the medicament.
摘要翻译：式（I）的化合物：[其中R 1表示低级烷基，X表示氧原子或亚甲基，m表示1〜10的整数，n表示0〜5的整数]或其盐或酯; 包含一种或多种这样的化合物的药物和药物组合物; 一种预防或治疗与雄激素密切相关的疾病的方法，其包括施用有效量的一种或多种这些化合物; 用于此类预防或治疗的试剂盒; 以及使用一种或多种这样的化合物来制造药物。

2. 发明授权

US07803826B2 Imidazolidine derivatives 有权
标题翻译：咪唑烷衍生物
公开(公告)号：US07803826B2
公开(公告)日：2010-09-28
申请号：US11659369
申请日：2005-08-03
申请人： Kazutaka Tachibana , Haruhiko Sato , Masateru Ohta , Mitsuaki Nakamura , Takuya Shiraishi , Ikuhiro Imaoka , Hitoshi Yoshino , Masahiro Nagamuta , Hiromitsu Kawata
发明人： Kazutaka Tachibana , Haruhiko Sato , Masateru Ohta , Mitsuaki Nakamura , Takuya Shiraishi , Ikuhiro Imaoka , Hitoshi Yoshino , Masahiro Nagamuta , Hiromitsu Kawata
IPC分类号： A61K31/4166 , C07D233/40
CPC分类号： C07D233/86 , C07D233/76
摘要： The present invention provides a compound represented by formula (I): wherein n is an integer selected from 1 to 20, Q is A is cyano or the like; B is hydrogen, halogen, or the like; X1 and X2 are each independently selected from O and S; E is a C1-4 alkyl group; and R1, R2, R3 and R4 are each independently selected from a hydrogen atom and a C1-C6 alkyl group, and a drug, a pharmaceutical composition containing the compound, and the like.
摘要翻译：本发明提供由式（I）表示的化合物：其中n是选自1至20的整数，Q是A是氰基等; B是氢，卤素等; X1和X2各自独立地选自O和S; E是C 1-4烷基; R 1，R 2，R 3和R 4各自独立地选自氢原子和C 1 -C 6烷基，以及药物，含有该化合物的药物组合物等。

3. 发明申请

US20070249697A1 Novel Imidazolidine Derivatives 有权
标题翻译：新型咪唑烷衍生物
公开(公告)号：US20070249697A1
公开(公告)日：2007-10-25
申请号：US11659369
申请日：2005-08-03
申请人： Kazutaka Tachibana , Haruhiko Sato , Masateru Ohta , Mitsuaki Nakamura , Takuya Shiraishi , Ikuhiro Imaoka , Hitoshi Yoshino , Masahiro Nagamuta , Hiromitsu Kawata
发明人： Kazutaka Tachibana , Haruhiko Sato , Masateru Ohta , Mitsuaki Nakamura , Takuya Shiraishi , Ikuhiro Imaoka , Hitoshi Yoshino , Masahiro Nagamuta , Hiromitsu Kawata
IPC分类号： A61K31/4164 , A61P5/26 , C07D233/00
CPC分类号： C07D233/86 , C07D233/76
摘要： The present invention provides a compound represented by formula (I): wherein n is an integer selected from 1 to 20, Q is A is cyano or the like; B is hydrogen, halogen, or the like; X1 and X2 are each independently selected from O and S; E is a C1-4 alkyl group; and R1, R2, R3 and R4 are each independently selected from a hydrogen atom and a C1-C6 alkyl group, and a drug, a pharmaceutical composition containing the compound, and the like.
摘要翻译：本发明提供由式（I）表示的化合物：其中n是选自1至20的整数，Q是A是氰基等; B是氢，卤素等; X 1和X 2各自独立地选自O和S; E是C 1-4烷基; 且R 1，R 2，R 3和R 4各自独立地选自氢原子和 C 1 -C 6烷基，以及药物，含有该化合物的药物组合物等。

4. 发明授权

US07271188B2 Imidazolidine derivatives 失效
标题翻译：咪唑烷衍生物
公开(公告)号：US07271188B2
公开(公告)日：2007-09-18
申请号：US10560281
申请日：2004-06-11
申请人： Kazutaka Tachibana , Haruhiko Sato , Masateru Ohta , Mitsuaki Nakamura , Takuya Shiraishi , Ikuhiro Imaoka , Hitoshi Yoshino , Masahiro Nagamuta , Hiromitsu Kawata
发明人： Kazutaka Tachibana , Haruhiko Sato , Masateru Ohta , Mitsuaki Nakamura , Takuya Shiraishi , Ikuhiro Imaoka , Hitoshi Yoshino , Masahiro Nagamuta , Hiromitsu Kawata
IPC分类号： A61K31/4166 , C07D233/86 , C07C311/03
CPC分类号： C07D233/86
摘要： The present invention provides a compound represented by formula (I):[Formula 1] wherein n is an integer selected from 1 to 20, and R1 and R2, which may be the same or different, each represent a hydrogen atom, or a linear or branched C1-C6 alkyl group, or a salt, a prodrug or a solvate thereof, as well as a drug, a pharmaceutical composition containing the compound, and the like.
摘要翻译：本发明提供由式（I）表示的化合物：[式1]其中n是选自1至20，R 1和R 2的整数，其中可以相同或不同，各自表示氢原子或直链或支链C 1 -C 6烷基，或其盐，前药或溶剂合物，以及药物，含有该化合物的药物组合物等。

5. 发明申请

US20060135583A1 Imidazolidine derivatives 失效
标题翻译：咪唑烷衍生物
公开(公告)号：US20060135583A1
公开(公告)日：2006-06-22
申请号：US10560281
申请日：2004-06-11
申请人： Kazutaka Tachibana , Haruhiko Sato , Masateru Ohta , Mitsuaki Nakamura , Takuya Shiraishi , Ikuhiro Imaoka , Hitoshi Yoshino , Masahiro Nagamuta , Hiromitsu Kawata
发明人： Kazutaka Tachibana , Haruhiko Sato , Masateru Ohta , Mitsuaki Nakamura , Takuya Shiraishi , Ikuhiro Imaoka , Hitoshi Yoshino , Masahiro Nagamuta , Hiromitsu Kawata
IPC分类号： A61K31/4166 , C07D233/76
CPC分类号： C07D233/86
摘要： The present invention provides a compound represented by formula (I): wherein n is an integer selected from 1 to 20, and R1 and R2, which may be the same or different, each represent a hydrogen atom, or a linear or branched C1-C6 alkyl group, or a salt, a prodrug or a solvate thereof, as well as a drug, a pharmaceutical composition containing the compound, and the like.
摘要翻译：本发明提供由式（I）表示的化合物：其中n是选自1至20的整数，R 1和R 2可以相同或不同的，各自表示氢原子或直链或支链C 1 -C 6烷基，或其盐，前药或溶剂合物，以及药物，含有该化合物的药物组合物等。

6. 发明授权

US08470829B2 Imidazolidine derivative and use thereof 失效
标题翻译：咪唑烷衍生物及其用途
公开(公告)号：US08470829B2
公开(公告)日：2013-06-25
申请号：US11662289
申请日：2005-09-09
申请人： Kazutaka Tachibana , Haruhiko Sato , Masateru Ohta , Mitsuaki Nakamura , Takuya Shiraishi , Hitoshi Yoshino , Takashi Emura , Akie Honma , Etsuro Onuma , Hiromitsu Kawata , Kenji Taniguchi
发明人： Kazutaka Tachibana , Haruhiko Sato , Masateru Ohta , Mitsuaki Nakamura , Takuya Shiraishi , Hitoshi Yoshino , Takashi Emura , Akie Honma , Etsuro Onuma , Hiromitsu Kawata , Kenji Taniguchi
IPC分类号： A61K31/426 , A61K31/454 , A61K31/428 , A61K31/4166 , C07D401/12 , C07D403/12 , C07D277/82 , C07D233/72 , C07D233/70
CPC分类号： C07D417/04 , C07D211/58 , C07D233/74 , C07D233/86 , C07D277/82 , C07D401/04
摘要： An imidazole derivative represented by formula (I): wherein Q is: A is hydrogen, halogen, or a substituted or unsubstituted C1-4 alkyl group; E is independently selected from a C1-6 alkyl group; R2 and R3 are independently selected from C1-6 alkyls; X1 and X2 are independently selected from O and S; Y is selected from a substituted or unsubstituted arylene group and a substituted or unsubstituted divalent 5- or 6-membered monocyclic or 8- to 10-membered condensed heterocyclic group; Z is —CON(—Ra)—, —CO—, —OOO—, —NRa—C(═NH)NRb—, —NRa—C(═N—CN)NRb—, —N(—Ra)COO—, —C(═NH)—, —SO2—, —SO2N(—Ra)—, —SO2NR1—, —N(—Ra)CO—, —N(—Ra)CON(—Rb)—, —N(COR1)CO—, —N(—Ra)SO2—, —N(SO2R1)SO2—, —N(—Ra)— or —N(—Ra)SO2N(—Rb)—; R1 is independently a hydrogen atom, a hydroxyl group, or substituted or unsubstituted group selected from C1-6 alkyl group, heterocyclic group, aryl group, C3-8 cycloalkyl group and C3-8 cycloalkenyl group; or salt or prodrug thereof.
摘要翻译：由式（I）表示的咪唑衍生物：其中Q是：A是氢，卤素或取代或未取代的C1-4烷基; E独立地选自C 1-6烷基; R2和R3独立地选自C1-6烷基; X1和X2独立地选自O和S; Y选自取代或未取代的亚芳基和取代或未取代的二价5元或6元单环或8至10元稠合杂环基; Z是-CON（-R a） - ， - CO - ， - OO-，-NR a -C（= NH）NR b - ， - NR a -C（= N-CN）NR b - ， - N（-R a），-C（= NH） - ， - SO 2 - ， - SO 2 N（-R a） - ， - SO 2 NR 1 - ， - N（-R a）CO - ， - N（-R a）CON（-R b） COR 1）CO - ， - N（-R a）SO 2 - ， - N（SO 2 R 1）SO 2 - ， - N（-R a） - 或-N（-R a）SO 2 N（-R b） R 1独立地为氢原子，羟基或取代或未取代的选自C 1-6烷基，杂环基，芳基，C 3-8环烷基和C 3-8环烯基的基团; 或其盐或前药。

7. 发明申请

US20110306615A1 NOVEL IMIDAZOLIDINE DERIVATIVE AND USE THEREOF 失效
公开(公告)号：US20110306615A1
公开(公告)日：2011-12-15
申请号：US11662289
申请日：2005-09-09
申请人： Kazutaka Tachibana , Haruhiko Sato , Masateru Ohta , Mitsuaki Nakamura , Takuya Shiraishi , Hitoshi Yoshino , Takashi Emura , Akie Honma , Etsuro Onuma , Hiromitsu Kawata , Kenji Taniguchi
发明人： Kazutaka Tachibana , Haruhiko Sato , Masateru Ohta , Mitsuaki Nakamura , Takuya Shiraishi , Hitoshi Yoshino , Takashi Emura , Akie Honma , Etsuro Onuma , Hiromitsu Kawata , Kenji Taniguchi
IPC分类号： A61K31/454 , C07D233/74 , C07D417/10 , C07D403/12 , C07D233/86 , C07D413/12 , A61K31/4166 , A61K31/428 , A61K31/496 , A61K31/4439 , A61K31/5377 , A61P35/00 , A61P13/08 , A61Q7/00 , A61P15/00 , A61P17/10 , C07D401/04
CPC分类号： C07D417/04 , C07D211/58 , C07D233/74 , C07D233/86 , C07D277/82 , C07D401/04
摘要： According to the present invention, a compound represented by formula (I): wherein Q is: A is a hydrogen atom, a halogen atom, —ORa or a C1-4 alkyl group which may be substituted by one or more halogen atoms; E is independently selected from a C1-6 alkyl group; m is selected from integers from 0 to 3; R2 and R3 are independently selected from a C1-6 alkyl group; X1 and X2 are independently selected from O and S; Y is selected from an arylene group and a divalent 5- or 6-membered monocyclic or 8- to 10-membered condensed heterocyclic group, wherein the arylene group and the heterocyclic group may be substituted by 1 to 3 substituents independently selected from E1; E1 is independently selected from a hydroxyl group, a halogen atom, a C1-4 alkyl group, a cyano group, a C1-4 alkoky group, a carbamoyl group, a C1-4 alkylcarbamoyl group, a di(C1-4 alkyl)carbamoyl group, an amino group, a C1-4 alkylamino group, a di(C1-4 alkylamino group, a sulfamoyl group, a C1-4 alkylsulfamoyl group and a di(C1-4 alkyl)sulfamoyl group; Z is —CON(—Ra)—, —CO—, —COO—, —NRa—C(═NH)NRb—, —NRa—C(═N—CN)NRb—, —N(—Ra)COO—, —C(═NH)—, —SO2—, —SO2N(—Ra)—, —SO2NR1—, —N(—Ra)CO—, —N(—Ra)CON(—Rb)—, —N(COR1)CO—, —N(—Ra)SO2—, —N(SO2R1)SO2—, —N(—Ra)— or —N(—Ra)SO2N(—Rb)—; R1 is independently a hydrogen atom, a hydroxyl group, a C1-6 alkyl group which may be substituted by one or more substituents, a heterocyclic group which may be substituted by one or more substituents, an aryl group which may be substituted by one or more substituents, a C3-8 cycloalkyl group which may be substituted by one or more substituents or a C3-8 cycloalkenyl group which may be substituted by one or more substituents, or a salt, prodrug or solvate thereof is provided. Furthermore, a pharmaceutical composition containing the compound, and the like are also provided.

8. 发明授权

US08660499B2 Delivery system, delivery apparatus, terminal apparatus and method 有权
标题翻译：配送系统，配送设备，终端设备及方法
公开(公告)号：US08660499B2
公开(公告)日：2014-02-25
申请号：US13060762
申请日：2009-08-13
申请人： Yuta Sagae , Hitoshi Yoshino
发明人： Yuta Sagae , Hitoshi Yoshino
IPC分类号： H04B1/00
CPC分类号： H04W48/10 , H04W48/12
摘要： A delivery system includes a delivery apparatus for delivering a common control signal to an area having one or more available communication systems and a terminal apparatus for receiving the common control signal transmitted from the delivery apparatus. The common control signal includes system information required to access the communication systems in the area, and the system information includes multiple control information items. The delivery system causes the delivery apparatus to generate a first common control signal commonly used in one or more areas, to receive a delivery request signal from the terminal apparatus requesting to deliver a certain control information item and to generate a second common control signal including the certain control information item to transmit to the terminal apparatus. Criteria to determine which of the control information items is to be included in the first common control signal are updated in accordance with a statistical tendency of the delivery request signals from the terminal apparatuses.
摘要翻译：传送系统包括用于将公共控制信号传送到具有一个或多个可用通信系统的区域的传送装置和用于接收从传送装置发送的公共控制信号的终端装置。公共控制信号包括访问该区域中的通信系统所需的系统信息，并且系统信息包括多个控制信息项。传送系统使得传送设备产生在一个或多个区域中通常使用的第一公共控制信号，以从终端设备接收请求传递某个控制信息项的传送请求信号，并产生包括第二公共控制信号的第二公共控制信号某些控制信息项目要发送到终端设备。根据来自终端装置的传送请求信号的统计趋势来更新确定哪个控制信息项将被包括在第一公共控制信号中的标准。

9. 发明授权

US08615191B2 Distribution apparatus, terminal apparatus, system, and method 失效
标题翻译：配电设备，终端设备，系统和方法
公开(公告)号：US08615191B2
公开(公告)日：2013-12-24
申请号：US13060642
申请日：2009-08-12
申请人： Yuta Sagae , Hitoshi Yoshino
发明人： Yuta Sagae , Hitoshi Yoshino
IPC分类号： H04H20/71
CPC分类号： H04W48/10
摘要： A distribution apparatus which distributes to multiple regions includes: a storage unit which stores each of radio communications systems usable for each of the regions; a selecting unit which selects, out of the multiple regions to which the distribution apparatus distributes, first regions in which a radio communications system in operation is the same; and a distribution unit which distributes, based on each of the radio communications system usable for each of the regions that is stored in the storage unit, all or some of information on the radio communications system for each of the first regions selected by the selecting unit. One or multiple radio communications systems are usable in each of the regions.
摘要翻译：分配到多个区域的分配装置包括：存储单元，其存储可用于每个区域的每个无线电通信系统; 选择单元，其在分配装置分配的多个区域中选择运行中的无线电通信系统相同的第一区域; 以及分发单元，其基于对于存储在存储单元中的每个区域可用的每个无线电通信系统，分配用于由选择单元选择的每个第一区域的无线电通信系统的全部或一些信息。一个或多个无线电通信系统可用于每个区域。

10. 发明授权

US08606323B2 Base station, terminal equipment, and method for mobile communication system in an environment where areas each including multiple radio communication systems coexist 有权
标题翻译：基站，终端设备及移动通信系统的方法，在各个无线通信系统共同存在的环境中
公开(公告)号：US08606323B2
公开(公告)日：2013-12-10
申请号：US12993347
申请日：2009-05-15
申请人： Yuta Sagae , Hitoshi Yoshino
发明人： Yuta Sagae , Hitoshi Yoshino
IPC分类号： H04W88/08 , H04W4/06 , H04H60/91
CPC分类号： H04W48/08 , H04W88/06 , H04W88/08
摘要： A base station includes an internal-area information storing unit storing system information necessary to connect to radio systems in an area to which the base station belongs; an external-area transmission method information storing unit storing external-area transmission method information indicating a method of transmitting a common control signal in an area adjacent to the area to which the base station belongs; and a transmitting unit wirelessly transmitting the common control signal including the system information stored in the internal-area information storing unit or the external-area transmission method information to the terminal equipment. The common control signal including the external-area transmission method information is transmitted at regular or irregular transmission timings.
摘要翻译：基站包括内部区域信息存储单元，其存储连接到基站所属的区域中的无线电系统所必需的系统信息; 外部区域传输方法信息存储单元，存储指示在与所述基站所属的区域相邻的区域中发送公共控制信号的方法的外部区域传输方法信息; 以及发送单元，将包含存储在内部区域信息存储单元中的系统信息的公共控制信号或者外部区域发送方法信息无线发送到终端设备。包括外部区域传输方法信息的公共控制信号以规则或不规则的传输定时发送。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式